Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

46.74
+0.60001.30%
Post-market: 46.810.0700+0.15%19:59 EDT
Volume:10.91M
Turnover:511.14M
Market Cap:206.73B
PE:11.68
High:47.17
Open:46.35
Low:46.34
Close:46.14
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.82
T/O Rate:0.34%
Dividend:1.72
Dividend Rate:3.68%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.35
PE(LYR):12.91

Loading ...

Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

TIPRANKS
·
Jul 18

Novo Nordisk to Launch Lower-cost Ozempic Copy in South Africa

Reuters
·
Jul 18

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 18

European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus

MT Newswires Live
·
Jul 17

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator

MT Newswires Live
·
Jul 17

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%

TIPRANKS
·
Jul 17

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live
·
Jul 16

United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk

MT Newswires Live
·
Jul 16

United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251

TIPRANKS
·
Jul 16

Moderately bullish activity in Novo Nordisk with shares up 2.46%

TIPRANKS
·
Jul 16

Sector Update: Healthcare

MT Newswires Live
·
Jul 16

Novo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial

TIPRANKS
·
Jul 16

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 16

Novo Nordisk announces European Commission approval of Wegovy pill

TIPRANKS
·
Jul 16

European Equities Traded in the US as American Depositary Receipts Advance Wednesday

MT Newswires Live
·
Jul 15

Novo Nordisk Rises as Oral Wegovy Captures 89% of US Oral Weight-Loss Prescriptions vs Eli Lilly

Market Focus
·
Jul 15

This Wall Street 'theme-o-meter' Has a Clear Message: the Artificial-intelligence Bull Market is Back

Dow Jones
·
Jul 15

Novo Nordisk Takes Early Lead in Oral Weight-Loss Drug Market, Eli Lilly Aims to Catch Up

Deep News
·
Jul 15

In the Weight-loss Wars, Novo's Obesity Pill is Pulling Way Ahead of Lilly's

Dow Jones
·
Jul 15